Prana Biotechnology Limited (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 91   

Articles published

PRAN 2.03 -0.01 (-0.49%)
price chart
Prana Biotechnology Is Still A Short After Recent Alzheimer's Failure
Recently, Prana Biotechnology (PRAN) had announced that its Phase II trial testing patients with Alzheimer's disease had failed.
Related articles »  
Why Prana Biotech's & Momenta Pharma's Stock Prices Fell Yesterday
3. prana-biotechnology-pran-momenta-pharmaceutical-mnta-news-why-. Biotech stocks took a strong hit yesterday, with Prana Biotechnology Limited (ADR) (PRAN) falling over 70% and Momenta Pharmaceuticals, Inc. (MNTA) sliding over 16%. Bidness Etc ...
Prana collapses after trial fails  Seeking Alpha
Volume Alert: Prana Biotechnology Limited (ADR) (NASDAQ:PRAN), Samson ...  Market News Call
Related articles »  
News Review - Prana Biotechnology Limited (ADR) (PRAN), Lexicon ...
... 2014 - 12:09 PM. Chicago, IL - April 24, 2014 - (Tech Sonian) - Prana Biotechnology Limited (ADR) (NASDAQ:PRAN), has declared the top line results of the 12-month Phase II Imaging trial in Alzheimer's Disease (�IMAGINE� Trial), based on draft results.
Related articles »  
Stocks in Queue - B2Gold Corp (NYSEMKT:BTG), Prana Biotechnology Limited ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) has reported the top line results of the 12-month Phase II Imaging trial in Alzheimer's Disease, based on draft results.
Related articles »  
Stocks in the News � NII Holdings Inc (NIHD), Prana Biotechnology Limited ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) released the top line outcome of the 12-month Phase II Imaging trial in Alzheimer's Disease (�IMAGINE� Trial), based on draft outcome.
Related articles »  
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN): The Research Programs ...
Boston, MA, 04/09/2014 (usastockreport) - Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) announces issue of ordinary shares to carry out its business proceeds.
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) Stops Erosion In Share ...  FinancialsTrend
Notable Movers: Prana Biotechnology Limited (ADR) (PRAN), Cincinnati Bell ...  Techsonian (press release)
Related articles »  
Hot Stocks Buzz: Prana Biotechnology (PRAN), The Wet Seal (WTSL), Gevo ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) jumped 8.62% after the recent news that the company's Phase 2 REACH2HD clinical trial investigating PBT2 as a cure for Huntington disease met its primary safety endpoint and achieved statistically ...
Bearish Stocks: MannKind Corporation (NASDAQ:MNKD), Prana Biotechnology ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) on Mar. 31 released the top line results of the 12-month Phase II Imaging trial in Alzheimer's Disease (�IMAGINE� Trial), based on draft results.
What's Hurting These 3 Stocks? � Prana Biotechnology Limited (ADR ...  Markets Emerging
Most Volatile Stocks: MannKind Corporation (NASDAQ:MNKD), Prana ...  Gaining Green
Related articles »  
5 Heavy Selloffs: Prana Biotechnology Limited (ADR) (PRAN), Liquidity Services ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) lost another 17.86% following a 71.60% fall on Monday after the Australian drug developer said its most advanced potential treatment failed to meet the main goal in a study of patients with Alzheimer's ...
Related articles »  
Traders Watch List - Dyax Corp. (NASDAQ:DYAX), Prana Biotechnology Limited ...
Stamford, Connecticut - 23rd April 2014- (Techsonian) - Dyax Corp. (NASDAQ:DYAX) will host a webcast and conference call, including an open question and answer session, Wednesday, April 30, 2014.
Related articles »